3-(2H-1,3-benzodioxol-5-yl)-1,2-oxazol-5-ol, 95.0%, 2g

1-Cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 1g

1-Chloro-3-chloromethyl-benzene, 97.0%, 25g

TERT-BUTYL (R)-2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PYRROLIDINE-1-CARBOXYLATE, 95.0%, 100mg

2,3-Difluoro-6-methoxybenzyl alcohol, 10g

7-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 10g

6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-N-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6S)-, 98%, 50mg

Four-necked round bottom flask Parallel side necks, 1000 ml, 29/32, 1 Piece

4-Phenoxybenzoyl chloride, 95.0%, 500mg

Long working distance plan phase contrast Fluarex 40x/0.65 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

6-(dibutylamino)-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dithione, 98%, 100g

1-[5-chloro-2-(difluoromethoxy)phenyl]ethan-1-one, 95%, 5g

Butyl[6-(butylamino)hexyl]amine, 98%, 100mg